"mesothelioma treatment" - Google News

Gene Test May Predict Who Responds to New Mesothelioma Drug - Mesothelioma Center

2026-07-22T07:00:00.000000000Z

Gene Test May Predict Who Responds to New Mesothelioma Drug Mesothelioma Center

Do Mesothelioma Patients Need to Worry About Chemotherapy Shortages? - Mesothelioma.net

2026-07-21T11:32:00.000000000Z

Do Mesothelioma Patients Need to Worry About Chemotherapy Shortages? Mesothelioma.net

First-Line Nivolumab Plus Ipilimumab in Inoperable Epithelioid Malignant Pleural Mesothelioma: Real-World Experience From an Indian Tertiary Care Center - Cureus

2026-07-24T17:19:31.000000000Z

First-Line Nivolumab Plus Ipilimumab in Inoperable Epithelioid Malignant Pleural Mesothelioma: Real-World Experience From an Indian Tertiary Care Center Cureus

Illinois Court Upholds $45 Million Judgment Against Johnson & Johnson - Mesothelioma Guide

2026-07-23T20:42:55.000000000Z

Illinois Court Upholds $45 Million Judgment Against Johnson & Johnson Mesothelioma Guide

What You Should Know About Mesothelioma in Younger Patients - Memorial Sloan Kettering Cancer Center

2026-03-31T07:00:00.000000000Z

What You Should Know About Mesothelioma in Younger Patients Memorial Sloan Kettering Cancer Center

A Long Shadow: Mapping Mesothelioma’s Uneven Decline Across the United States - University of Miami

2026-06-11T07:00:00.000000000Z

A Long Shadow: Mapping Mesothelioma’s Uneven Decline Across the United States University of Miami

On the horizon: proton beam therapy for mesothelioma - Hospital Healthcare Europe

2026-05-27T07:00:00.000000000Z

On the horizon: proton beam therapy for mesothelioma Hospital Healthcare Europe

Study reports a counterintuitive new approach to treating mesothelioma - News-Medical

2026-07-14T07:00:00.000000000Z

Study reports a counterintuitive new approach to treating mesothelioma News-Medical

AI model proves to be a heavyweight in tumor assessment: Mesothelioma patients and physicians benefit - Medical Xpress

2026-06-17T07:00:00.000000000Z

AI model proves to be a heavyweight in tumor assessment: Mesothelioma patients and physicians benefit Medical Xpress

Yearly Recap: 2025 Mesothelioma Research Advances - Mesothelioma.com

2026-01-14T08:00:00.000000000Z

Yearly Recap: 2025 Mesothelioma Research Advances Mesothelioma.com

Pleurectomy Decortication Safe in Select Patients With Pleural Mesothelioma - The ASCO Post

2026-02-18T08:00:00.000000000Z

Pleurectomy Decortication Safe in Select Patients With Pleural Mesothelioma The ASCO Post

Innovative New Technique Destroys 99% of Cancer Cells, Offering Hope for Mesothelioma - Mesothelioma.net

2026-07-20T11:19:00.000000000Z

Innovative New Technique Destroys 99% of Cancer Cells, Offering Hope for Mesothelioma Mesothelioma.net

Best Treatment for Mesothelioma in 2026? Combination of Surgery and Systemic - Mesothelioma Guide

2026-05-22T07:00:00.000000000Z

Best Treatment for Mesothelioma in 2026? Combination of Surgery and Systemic Mesothelioma Guide

Immunotherapy & Peritoneal Meso: 4 Key Facts for Patients - Mesothelioma.com

2026-06-24T07:00:00.000000000Z

Immunotherapy & Peritoneal Meso: 4 Key Facts for Patients Mesothelioma.com

Haemophagocytic Lymphohistiocytosis Following Ipilimumab and Nivolumab in Malignant Pleural Mesothelioma: A Case Report - Cureus

2026-07-16T15:26:14.000000000Z

Haemophagocytic Lymphohistiocytosis Following Ipilimumab and Nivolumab in Malignant Pleural Mesothelioma: A Case Report Cureus

Why Immunotherapy Works for Some, But Not All, Mesothelioma Patients - University of Miami

2026-05-05T07:00:00.000000000Z

Why Immunotherapy Works for Some, But Not All, Mesothelioma Patients University of Miami

FDA Grants Orphan Drug Designation to Mesothelioma Treatment - Mesothelioma.net

2026-04-21T07:00:00.000000000Z

FDA Grants Orphan Drug Designation to Mesothelioma Treatment Mesothelioma.net

PRX3 Inhibitor Produces Promising Results in Pleural Mesothelioma - Mesothelioma Guide

2026-07-17T18:13:31.000000000Z

PRX3 Inhibitor Produces Promising Results in Pleural Mesothelioma Mesothelioma Guide

Mesothelioma Treatment Receives Second Orphan Drug Designation - Mesothelioma.net

2026-06-23T07:00:00.000000000Z

Mesothelioma Treatment Receives Second Orphan Drug Designation Mesothelioma.net

MSK Research Highlights, June 11, 2026 - Memorial Sloan Kettering Cancer Center

2026-06-11T07:00:00.000000000Z

MSK Research Highlights, June 11, 2026 Memorial Sloan Kettering Cancer Center

Mount Sinai Study Strengthens Landmark Evidence Supporting Lung-Sparing Surgery, Offering Hope for Mesothelioma Patients - Mount Sinai

2026-02-12T14:58:40.000000000Z

Mount Sinai Study Strengthens Landmark Evidence Supporting Lung-Sparing Surgery, Offering Hope for Mesothelioma Patients Mount Sinai

FDA Grants Fast Tract Designation to VT3989 for Mesothelioma - Cure Today

2025-10-09T07:00:00.000000000Z

FDA Grants Fast Tract Designation to VT3989 for Mesothelioma Cure Today

Will New Tumor Injection Be a Breakthrough for Mesothelioma Patients? - Mesothelioma.net

2026-06-16T07:00:00.000000000Z

Will New Tumor Injection Be a Breakthrough for Mesothelioma Patients? Mesothelioma.net

Proton Beam Therapy Trial Offers Hope for Better Mesothelioma Survival Outcomes - Mesothelioma.net

2026-03-12T07:00:00.000000000Z

Proton Beam Therapy Trial Offers Hope for Better Mesothelioma Survival Outcomes Mesothelioma.net

Can AI Treat Mesothelioma? AI Cancer Detection 2026 - Sokolove Law

2026-02-24T08:00:00.000000000Z

Can AI Treat Mesothelioma? AI Cancer Detection 2026 Sokolove Law

Mesothelioma remains deadly despite declining asbestos exposure rates - News-Medical

2026-06-11T07:00:00.000000000Z

Mesothelioma remains deadly despite declining asbestos exposure rates News-Medical

Stanford Surgeons Perform First PITAC Procedure for Pleural Mesothelioma - Mesothelioma Guide

2026-06-22T07:00:00.000000000Z

Stanford Surgeons Perform First PITAC Procedure for Pleural Mesothelioma Mesothelioma Guide

United Kingdom Clinical Trial Will Test Proton Beam Therapy for Mesothelioma - Mesothelioma.net

2026-06-10T07:00:00.000000000Z

United Kingdom Clinical Trial Will Test Proton Beam Therapy for Mesothelioma Mesothelioma.net

Opdivo and Yervoy for Mesothelioma - Mesothelioma Guide

2026-06-30T07:00:00.000000000Z

Opdivo and Yervoy for Mesothelioma Mesothelioma Guide

Immune Checkpoint Inhibitors for Mesothelioma - Mesothelioma.net

2026-04-21T07:00:00.000000000Z

Immune Checkpoint Inhibitors for Mesothelioma Mesothelioma.net

Mesothelioma Drug Development Targeting HIPPO Pathway Proves Challenging - Mesothelioma.net

2026-01-20T08:00:00.000000000Z

Mesothelioma Drug Development Targeting HIPPO Pathway Proves Challenging Mesothelioma.net

Study Shows Immune Cell Clusters Predict Which Mesothelioma Patients Will Live Longer - Mesothelioma.net

2026-04-30T07:00:00.000000000Z

Study Shows Immune Cell Clusters Predict Which Mesothelioma Patients Will Live Longer Mesothelioma.net

Clinical Trials - Mesothelioma Hub

2026-01-23T08:00:00.000000000Z

Clinical Trials Mesothelioma Hub

How Scar Tissue Affects Mesothelioma Surgery After Chemotherapy - Mesothelioma.net

2026-07-03T15:31:20.000000000Z

How Scar Tissue Affects Mesothelioma Surgery After Chemotherapy Mesothelioma.net

Mesothelioma in Younger Patients: Doctors Want to Know Why - Mesothelioma Center

2026-04-20T07:00:00.000000000Z

Mesothelioma in Younger Patients: Doctors Want to Know Why Mesothelioma Center

Stanford Performs First PITAC Procedure for Mesothelioma in North America - Stanford Medicine

2026-06-11T07:00:00.000000000Z

Stanford Performs First PITAC Procedure for Mesothelioma in North America Stanford Medicine

Immunotherapy Study Shows 22% Improved Survival in Mesothelioma - Mesothelioma.net

2025-12-24T08:00:00.000000000Z

Immunotherapy Study Shows 22% Improved Survival in Mesothelioma Mesothelioma.net

Proton beam hope for asbestos cancer patients - BBC

2026-03-11T07:00:00.000000000Z

Proton beam hope for asbestos cancer patients BBC

Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma - Frontiers

2026-05-29T14:24:08.000000000Z

Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma Frontiers

Phase I Trial of New Cell Therapy Shows Promise for Mesothelioma - Mesothelioma.net

2026-04-24T07:00:00.000000000Z

Phase I Trial of New Cell Therapy Shows Promise for Mesothelioma Mesothelioma.net

Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models - Nature

2026-02-11T08:00:00.000000000Z

Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models Nature

Peritoneal Mesothelioma Survivor Shares Ongoing Reality of Survivorship - Cure Today

2025-11-02T07:00:00.000000000Z

Peritoneal Mesothelioma Survivor Shares Ongoing Reality of Survivorship Cure Today

New KIR-CAR T cell therapy shows promise in solid cancers - Penn Medicine

2026-04-20T07:00:00.000000000Z

New KIR-CAR T cell therapy shows promise in solid cancers Penn Medicine

New proton beam therapy trial targets mesothelioma - UCL | University College London

2026-03-11T07:00:00.000000000Z

New proton beam therapy trial targets mesothelioma UCL | University College London

First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma - Johns Hopkins Medicine

2025-09-08T07:00:00.000000000Z

First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma Johns Hopkins Medicine

How Artificial Intelligence Is Changing Mesothelioma Care - Mesothelioma.net

2025-12-23T08:00:00.000000000Z

How Artificial Intelligence Is Changing Mesothelioma Care Mesothelioma.net

Mesothelioma Statistics 2026 | Cases & Death Rates - Sokolove Law

2026-07-01T07:00:00.000000000Z

Mesothelioma Statistics 2026 | Cases & Death Rates Sokolove Law

Proposed Peritoneal Mesothelioma Staging Could Fill Critical Gap - Mesothelioma Center

2026-02-12T08:00:00.000000000Z

Proposed Peritoneal Mesothelioma Staging Could Fill Critical Gap Mesothelioma Center

FDA Grants Fast Track Designation to VT3989 for Unresectable Mesothelioma - OncLive

2025-10-08T07:00:00.000000000Z

FDA Grants Fast Track Designation to VT3989 for Unresectable Mesothelioma OncLive

Immunotherapy Timing | Do AM Infusions Boost Survival? - Mesothelioma.com

2026-03-18T07:00:00.000000000Z

Immunotherapy Timing | Do AM Infusions Boost Survival? Mesothelioma.com

Innovative Research Investigating a New Treatment for Mesothelioma - Worldwide Cancer Research

2026-04-01T07:00:00.000000000Z

Innovative Research Investigating a New Treatment for Mesothelioma Worldwide Cancer Research

Study Strengthens Evidence for Pleurectomy / Decortication for Mesothelioma - respiratory-therapy.com

2026-02-18T05:35:10.000000000Z

Study Strengthens Evidence for Pleurectomy / Decortication for Mesothelioma respiratory-therapy.com

Case Report: Clinical course and extended survival in a canine patient with pericardial mesothelioma managed without chemotherapeutic intervention - Frontiers

2026-04-30T19:13:23.000000000Z

Case Report: Clinical course and extended survival in a canine patient with pericardial mesothelioma managed without chemotherapeutic intervention Frontiers

Inside Mesothelioma Care: Dr. Jeffrey Velotta on Surgery and Treatment - mesotheliomahelp.org

2026-05-29T07:00:00.000000000Z

Inside Mesothelioma Care: Dr. Jeffrey Velotta on Surgery and Treatment mesotheliomahelp.org

Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolytics | Cell Death & Disease - Nature

2026-04-10T07:00:00.000000000Z

Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolytics | Cell Death & Disease Nature

Imfinzi With Chemo Produces Inconclusive Outcomes in Phase 3 Mesothelioma Study - Cure Today

2025-10-19T07:00:00.000000000Z

Imfinzi With Chemo Produces Inconclusive Outcomes in Phase 3 Mesothelioma Study Cure Today

Five-Year Study Confirms Lasting Benefits of Immunotherapy for Mesothelioma - mesotheliomahelp.org

2026-03-11T07:00:00.000000000Z

Five-Year Study Confirms Lasting Benefits of Immunotherapy for Mesothelioma mesotheliomahelp.org

Should Surgery Be Performed for Sarcomatoid Mesothelioma? - mesotheliomahelp.org

2026-06-03T07:00:00.000000000Z

Should Surgery Be Performed for Sarcomatoid Mesothelioma? mesotheliomahelp.org

Malignant mesothelioma in rare sites: two case reports - Frontiers

2025-11-28T08:00:00.000000000Z

Malignant mesothelioma in rare sites: two case reports Frontiers

Mesothelioma Financial Assistance & Support in 2026 - Sokolove Law

2026-07-01T07:00:00.000000000Z

Mesothelioma Financial Assistance & Support in 2026 Sokolove Law

Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report - Cureus

2026-06-01T07:00:00.000000000Z

Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report Cureus

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma - UT MD Anderson

2025-10-19T07:00:00.000000000Z

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma UT MD Anderson

AI model proves to be a heavyweight in tumor assessment: Mesothelioma patients and physicians benefit - EurekAlert!

2026-06-17T07:00:00.000000000Z

AI model proves to be a heavyweight in tumor assessment: Mesothelioma patients and physicians benefit EurekAlert!

Orion Pharma’s ODM-212 Granted Orphan Designation for the - GlobeNewswire

2026-06-23T07:00:00.000000000Z

Orion Pharma’s ODM-212 Granted Orphan Designation for the GlobeNewswire

Five-Year Outcomes With First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma - The ASCO Post

2026-03-06T08:00:00.000000000Z

Five-Year Outcomes With First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma The ASCO Post

KIR-CAR: a multichain CAR-T model advancing solid tumor treatment - RegMedNet

2026-04-22T07:00:00.000000000Z

KIR-CAR: a multichain CAR-T model advancing solid tumor treatment RegMedNet

Isolated primary pericardial sarcomatoid mesothelioma: a case report - Frontiers

2026-03-19T20:17:47.000000000Z

Isolated primary pericardial sarcomatoid mesothelioma: a case report Frontiers

A new treatment path for mesothelioma: Join the Baylor clinical trial - Baylor College of Medicine Blog Network -

2025-09-03T07:00:00.000000000Z

A new treatment path for mesothelioma: Join the Baylor clinical trial Baylor College of Medicine Blog Network -

How Flexible Work Helps Cancer Patients Balance Treatment and Recovery - Mesothelioma Center

2025-10-29T12:20:26.000000000Z

How Flexible Work Helps Cancer Patients Balance Treatment and Recovery Mesothelioma Center

A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing - Nature

2025-11-21T08:00:00.000000000Z

A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing Nature

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models | Scientific Reports - Nature

2026-02-25T08:00:00.000000000Z

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models | Scientific Reports Nature

Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses - Nature

2025-09-08T07:00:00.000000000Z

Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses Nature

UH Cancer Center identifies treatable form of mesothelioma - University of Hawaii System

2025-09-30T07:00:00.000000000Z

UH Cancer Center identifies treatable form of mesothelioma University of Hawaii System

Study Shows Overall Mesothelioma Rates Have Fallen Since 1990 - Mesothelioma Guide

2026-06-17T07:00:00.000000000Z

Study Shows Overall Mesothelioma Rates Have Fallen Since 1990 Mesothelioma Guide

Opdivo-Yervoy Tops Chemotherapy in Mesothelioma Survival - Mesothelioma Guide

2026-03-06T08:00:00.000000000Z

Opdivo-Yervoy Tops Chemotherapy in Mesothelioma Survival Mesothelioma Guide

Paul Kraus, Mesothelioma Survivor - Mesothelioma Guide

2026-03-31T07:00:00.000000000Z

Paul Kraus, Mesothelioma Survivor Mesothelioma Guide

Here's How To Tell if You're at Risk for Mesothelioma - Health: Trusted and Empathetic Health and Wellness Information

2025-09-28T07:00:00.000000000Z

Here's How To Tell if You're at Risk for Mesothelioma Health: Trusted and Empathetic Health and Wellness Information

Mesothelioma in Adults: What patients should know about: Update 2024 - Oncodaily

2025-10-31T07:00:00.000000000Z

Mesothelioma in Adults: What patients should know about: Update 2024 Oncodaily

Mesothelioma Awareness Day: A Patient's 10-Year Journey and Perspective - Targeted Oncology

2025-09-26T07:00:00.000000000Z

Mesothelioma Awareness Day: A Patient's 10-Year Journey and Perspective Targeted Oncology

Why Immunotherapy Works for Some Mesothelioma Patients but Not Others: New Research Highlights the Role of DNA Methylation - Onco'Zine

2026-05-11T07:00:00.000000000Z

Why Immunotherapy Works for Some Mesothelioma Patients but Not Others: New Research Highlights the Role of DNA Methylation Onco'Zine

Finding the right target: Personalising treatment for an aggressive asbestos-linked cancer - University of Leicester

2026-06-17T07:00:00.000000000Z

Finding the right target: Personalising treatment for an aggressive asbestos-linked cancer University of Leicester

Mesothelioma: reviewing the therapy pipeline - Oncology Central

2026-01-27T08:00:00.000000000Z

Mesothelioma: reviewing the therapy pipeline Oncology Central

Mesothelioma Blood Test, Pre-Surgery Immunotherapy Offer Hope - Mesothelioma Center

2025-09-16T07:00:00.000000000Z

Mesothelioma Blood Test, Pre-Surgery Immunotherapy Offer Hope Mesothelioma Center

Dipesh Uprety, MD | Oncologist, Mesothelioma & Lung Cancer - Mesothelioma.net

2026-06-18T07:00:00.000000000Z

Dipesh Uprety, MD | Oncologist, Mesothelioma & Lung Cancer Mesothelioma.net

VT3989 Demonstrates Antitumor Activity and Tolerability in Refractory Mesothelioma - The ASCO Post

2025-10-20T07:00:00.000000000Z

VT3989 Demonstrates Antitumor Activity and Tolerability in Refractory Mesothelioma The ASCO Post

Data from two novel TEAD inhibitors provide the first evidence for the efficacy and safety of targeted treatments in mesothelioma - ESMO Daily Reporter

2025-10-29T07:00:00.000000000Z

Data from two novel TEAD inhibitors provide the first evidence for the efficacy and safety of targeted treatments in mesothelioma ESMO Daily Reporter

Beyond the Buzz: Tumor Treating Fields for Cancer - Medscape

2025-12-01T08:00:00.000000000Z

Beyond the Buzz: Tumor Treating Fields for Cancer Medscape

ARTIMES AI Volumetry May Improve Response Assessment in Pleural Mesothelioma - Oncodaily

2026-06-19T07:00:00.000000000Z

ARTIMES AI Volumetry May Improve Response Assessment in Pleural Mesothelioma Oncodaily

New Study Says Pleurectomy/Decortication Safe - Mesothelioma Guide

2026-02-24T08:00:00.000000000Z

New Study Says Pleurectomy/Decortication Safe Mesothelioma Guide

Lung Leavin’ Day: 20 Years of Smashing Fears & Celebrating Life - Mesothelioma.com

2026-01-22T08:00:00.000000000Z

Lung Leavin’ Day: 20 Years of Smashing Fears & Celebrating Life Mesothelioma.com

Pleural Mesothelioma: Pathogenesis, Diagnosis, Treatment, Prognosis, and Survival - Zhang - 2025 - MedComm - Wiley Online Library

2025-09-01T07:00:00.000000000Z

Pleural Mesothelioma: Pathogenesis, Diagnosis, Treatment, Prognosis, and Survival - Zhang - 2025 - MedComm Wiley Online Library

Vermont - Mesothelioma Hub

2025-12-28T09:34:43.000000000Z

Vermont Mesothelioma Hub

Could Discovery Regarding COVID-19 mRNA Vaccines Help Mesothelioma Patients? - Mesothelioma.net

2025-10-27T07:00:00.000000000Z

Could Discovery Regarding COVID-19 mRNA Vaccines Help Mesothelioma Patients? Mesothelioma.net

Use of patient-derived organoids for pleural mesothelioma 3-D modeling - American Physiological Society Journal

2025-11-05T00:38:10.000000000Z

Use of patient-derived organoids for pleural mesothelioma 3-D modeling American Physiological Society Journal

What Is Asbestos Poisoning? First Signs & Symptoms (2026) - Sokolove Law

2026-03-06T08:00:00.000000000Z

What Is Asbestos Poisoning? First Signs & Symptoms (2026) Sokolove Law

Durvalumab Plus Chemo Yields Inconclusive Results in Advanced Pleural Mesothelioma - OncLive

2025-10-19T07:00:00.000000000Z

Durvalumab Plus Chemo Yields Inconclusive Results in Advanced Pleural Mesothelioma OncLive

National Nurses Week Spotlight: A Nurse Navigator’s Role in Mesothelioma Care - Mesothelioma Guide

2026-05-09T07:00:00.000000000Z

National Nurses Week Spotlight: A Nurse Navigator’s Role in Mesothelioma Care Mesothelioma Guide

Mesothelioma Continues to Leave a Lasting Mark Across the United States, New Research Finds - mesotheliomahelp.org

2026-06-12T07:00:00.000000000Z

Mesothelioma Continues to Leave a Lasting Mark Across the United States, New Research Finds mesotheliomahelp.org

CAR T-cell Therapy for Mesothelioma Impresses in Study - Mesothelioma Guide

2025-11-05T08:00:00.000000000Z

CAR T-cell Therapy for Mesothelioma Impresses in Study Mesothelioma Guide

Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies - Wiley & Sons

2025-10-24T07:00:00.000000000Z

Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies Wiley & Sons